• Return to HOME


  • Home
  • Services
    • Clinical & Medical Consulting
    • Business Development
    • Pharmaceutical
    • Regulatory Affairs
    • Legal Consulting
  • Our Team
    • Michael Epstein, MD, FACG, AGAF
  • News
  • Blog
  • Contact


Clinical & Medical Consulting

Our consulting services are second to none. Let our team guide you through the intensive processes concerning clinical research, medical device and technology, and regulatory affairs.

IBS Clinical Study – IBgard® and IBSREST™

Targeted delivery of peppermint oil to the small intestine provides significant improvement in the syndrome of symptoms associated with Irritable Bowel Syndrome.

IBgard®, a novel small intestine targeted delivery system of peppermint oil, results in significant improvement in severe and unbearable IBS symptom intensity. Results from the US based, 4-week, randomized, placebo-controlled, multi-center IBSREST™ trial.

24 hour results from a US based, randomized, placebo-controlled, multi-centered trial, to evaluate a novel peppermint oil delivery system. Results from the IBSREST™ trial.

IBgard®, a novel targeted delivery system of peppermint oil, results in significant improvement in the Total IBS Symptom Score and individual IBS symptoms. Results from the US based, 4-week, randomized, placebo controlled, multi-center IBSREST™ trial

Key Services

  • Clinical & Medical Consulting
  • Business Development
  • Pharmaceutical
  • Regulatory Affairs
  • Legal Consulting

News & Announcements

Achieving successful bowel preparation with evening/morning split-dosing regimens of NER1006 versus trisulfate: post hoc analysis of a Phase 3 trial
Jul 25, 2017
Novel 1L Polyethylene Glycol (PEG)-Based Bowel Preparation NER1006 Achieves High Quality Bowel Cleansing with a Lower Volume than Standard 2L PEG + Ascorbate and Under 3L Total Fluid Volume Intake
Jul 25, 2017
Bowel preparation quality of NER1006 versus oral trisulfate solution as assessed by colonoscopists at site: a post hoc analysis from a randomized controlled trial
Jul 25, 2017

410-224-4887 x453

Epstein Associates, LLC
621 Ridgely Avenue, Suite 204
Annapolis, MD 21401

  • Home
  • Services
  • Our Team
  • News
  • Blog
  • Contact

© Copyright 2015, Epstein Associates, LLC
Website Design by Calvert Design Group, Inc.